Abstract
Ibandronate is a potent nitrogen-containing bisphosphonate with a tertiary amine group, which does not easily form chromophore derivatives that can be detected by UV light of fluorescence emission. Here, a simple and straightforward automated multicommutated flow system, making use of water-soluble mercaptopropionic acid-capped CdTe quantum dots, was implemented for the fluorescence quantitation of ibandronate in pharmaceutical formulations. The developed approach was based on the analyte ability to establish surface interactions that resulted in quenched nanocrystals fluorescence intensity, being this effect proportional to the target compound’s concentration. Size and concentration of quantum dots and pH of the media were some of the most relevant and influencing parameters studied. The proposed methodology allowed the determination of ibandronate in the range of 20-200 µg mL-1, with good repeatability (RSD<3%) and a sampling frequency of about 70 samples per hour. The results obtained in the analysis of pharmaceuticals showed excellent agreement with those provided by the manufacturer.
Keywords: Automation, CdTe quantum dots, ibandronate, luminescence, multicommutation, nanoparticle.
Current Pharmaceutical Analysis
Title:Rapid Fluorimetric Quantitation of Ibandronate by Coupling Quantum Dots and Multicommutated Flow Injection Analysis
Volume: 9 Issue: 3
Author(s): A. Ruiz-Medina, L. Molina-Garcia, E.J. Llorent-Martinez, J.L.M. Santos and M.L. Fernandez-de Cordova
Affiliation:
Keywords: Automation, CdTe quantum dots, ibandronate, luminescence, multicommutation, nanoparticle.
Abstract: Ibandronate is a potent nitrogen-containing bisphosphonate with a tertiary amine group, which does not easily form chromophore derivatives that can be detected by UV light of fluorescence emission. Here, a simple and straightforward automated multicommutated flow system, making use of water-soluble mercaptopropionic acid-capped CdTe quantum dots, was implemented for the fluorescence quantitation of ibandronate in pharmaceutical formulations. The developed approach was based on the analyte ability to establish surface interactions that resulted in quenched nanocrystals fluorescence intensity, being this effect proportional to the target compound’s concentration. Size and concentration of quantum dots and pH of the media were some of the most relevant and influencing parameters studied. The proposed methodology allowed the determination of ibandronate in the range of 20-200 µg mL-1, with good repeatability (RSD<3%) and a sampling frequency of about 70 samples per hour. The results obtained in the analysis of pharmaceuticals showed excellent agreement with those provided by the manufacturer.
Export Options
About this article
Cite this article as:
Ruiz-Medina A., Molina-Garcia L., Llorent-Martinez E.J., Santos J.L.M. and Cordova M.L. Fernandez-de, Rapid Fluorimetric Quantitation of Ibandronate by Coupling Quantum Dots and Multicommutated Flow Injection Analysis, Current Pharmaceutical Analysis 2013; 9 (3) . https://dx.doi.org/10.2174/1573412911309030002
DOI https://dx.doi.org/10.2174/1573412911309030002 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Graphene Oxide-Based Nanocarriers for Cancer Imaging and Drug Delivery
Current Pharmaceutical Design Age-Related Changes in P-Glycoprotein Expression in Senescence- Accelerated Mouse
Current Aging Science Apixaban - Metabolism, Pharmacologic Properties and Drug Interactions
Current Drug Metabolism Editorial
Current Cancer Therapy Reviews Imaging Primary Brain Tumors by Single-Photon Emission Computerized Tomography (SPECT) with Technetium-99m Sestamibi (MIBI) and Tetrofosmin
Current Medical Imaging TP73, An Under-Appreciated Player in Non-Hodgkin Lymphoma Pathogenesis and Management
Current Molecular Medicine Chemotherapeutic Targeting of Cell Death Pathways
Anti-Cancer Agents in Medicinal Chemistry Radiological Screening Programs for Women at High Risk of Developing Breast Cancer
Current Women`s Health Reviews Unsafe Abortion: The Silent Endemic; An Avoidable Cause of Maternal Mortality. A Review
Current Women`s Health Reviews Inhibitors of the HSP90 Molecular Chaperone: Attacking the Master Regulator in Cancer
Current Topics in Medicinal Chemistry Analytical Methods for Metallothionein Detection
Current Analytical Chemistry The Network of Fibroblastic Reticular Cells in the Lymph Node:Functional Framework for Immune Surveillance
Current Immunology Reviews (Discontinued) The p53-p66Shc Apoptotic Pathway is Dispensable for Tumor Suppression whereas the p66Shc-generated Oxidative Stress Initiates Tumorigenesis
Current Pharmaceutical Design Targeted Cancer Therapy; Nanotechnology Approaches for Overcoming Drug Resistance
Current Medicinal Chemistry The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness
Current Drug Targets Smart Inulin-Based Polycationic Nanodevices for siRNA Delivery
Current Drug Delivery Incorporation of Anti-angiogenic Therapies in the Treatment of Epithelial Ovarian Cancer: Current Perspectives and Future Directions
Current Angiogenesis (Discontinued) Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 1. Selective Enzyme Inhibitors
Current Drug Targets Combinatorial Nanoparticles for Cancer Diagnosis and Therapy
Current Medicinal Chemistry Synergistic Approaches to Clinical Oncology Biomarker Discovery
Current Topics in Medicinal Chemistry